Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis
Journal of Hematology and Blood Disorders · 2016
DOI: 10.15744/2455-7641.2.105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology and Blood Disorders, 2016. Verfasst von Le Calloch R und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
R, L. C., A, C., F, B., A, D., D, L. P., N, D., I, Q., G, G., M, M., C, B., V, U., & JC, I. (2016). Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis. Journal of Hematology and Blood Disorders. https://doi.org/10.15744/2455-7641.2.105
Vancouver
R LC, A C, F B, A D, D LP, N D, et al. Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis. Journal of Hematology and Blood Disorders. 2016. doi:10.15744/2455-7641.2.105
BibTeX
@article{R2016,
author = {R, Le Calloch and A, Chauveau and F, Boyer-Perrard and A, Dagorne and D, Luque Paz and N, Douet-Guilbert and I, Quintin-Roué and G, Guillerm and M, Mercier and C, Berthou and V, Ugo and JC, Ianotto},
title = {Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis},
journal = {Journal of Hematology and Blood Disorders},
year = {2016},
doi = {10.15744/2455-7641.2.105}
}
EUVIMED